Hypertension

β-Blockers in Early Pregnancy Not Linked to Cardiac Malformation Risk

β-Blockers in Early Pregnancy Not Linked to Cardiac Malformation Risk

By

The use of β-blockers in the first trimester of pregnancy may not greatly increase the risk for major congenital malformations in offspring.

Intensive BP Therapy in Diabetes May Lower Risk for CV Events

Intensive BP Therapy in Diabetes May Lower Risk for CV Events

Intensive BP therapy is associated with significantly lower risk for cardiovascular events based on data reweighted to better reflect the US adult population with diabetes.

Implementing Updated Hypertension Guideline Directs Treatment to Those With High CVD Risk

Implementing Updated Hypertension Guideline Directs Treatment to Those With High CVD Risk

Implementing the updated ACC/AHA guideline would direct antihypertensive medications to adults with high risk of cardiovascular disease.

Southern Dietary Patterns May Mediate Racial Differences in HTN Incidence

Southern Dietary Patterns May Mediate Racial Differences in HTN Incidence

The Southern dietary pattern is the largest mediating factor for differences in the incidence of hypertension in black men and women.

Long-Term Exposure to Elevated BP Associated With AS and AR

Long-Term Exposure to Elevated BP Associated With AS and AR

By

An association was found between increased systolic blood pressure and risk for aortic stenosis and regurgitation.

Reverse Nocturnal BP Dipping Identifies CV Dysautonomia in Parkinson Disease

Reverse Nocturnal BP Dipping Identifies CV Dysautonomia in Parkinson Disease

By

A greater proportion of patients with dysautonomia had supine hypertension compared with patients without dysautonomia.

Does Adding Hypertensive Disorders of Pregnancy to CVD Risk Score Improve Risk Discrimination?

Does Adding Hypertensive Disorders of Pregnancy to CVD Risk Score Improve Risk Discrimination?

By

Adding history of hypertensive disorders of pregnancy to the current cardiovascular disease (CVD) risk score does not improve CVD prediction in low-risk women.

Intensive BP Control Beneficial in Hypertensive Individuals Regardless of BMI

Intensive BP Control Beneficial in Hypertensive Individuals Regardless of BMI

By

The overall impact of intensive blood pressure control led to beneficial effects on cardiovascular outcomes across the spectrum of BMI models.

Systolic Blood Pressure Variability Linked to Neurologic Outcomes in Intracerebral Hemorrhage

Systolic Blood Pressure Variability Linked to Neurologic Outcomes in Intracerebral Hemorrhage

By

The primary outcome was an unfavorable neurologic outcome, which was defined as a modified Rankin Scale score of 3 to 6 at 3 months following randomization.

Triple combination antihypertension therapy improves blood pressure control for mild-to-moderate hypertension

In this randomized controlled trial, patients receiving triple combination antihypertension therapy (TCAT) were more likely to achieve their blood pressure target compared to those with usual care at 6 months.

Hypertension Treatment Intensification Common Upon Hospital Discharge in Elderly

Hypertension Treatment Intensification Common Upon Hospital Discharge in Elderly

Fourteen percent of older adults hospitalized with non-cardiac conditions are discharged with intensified antihypertensive treatment, of whom more than half had previously well-controlled outpatient blood pressure.

Greater CVD Risk in Certain Age Groups With New Hypertension Guidelines

Greater CVD Risk in Certain Age Groups With New Hypertension Guidelines

By

Individuals who would now be classified as having stage 1 hypertension according to the new American College of Cardiology/American Heart Association blood pressure guidelines also have an increased risk for cardiovascular events.

No Apparent Short-Term Cancer Risk From Recalled Valsartan

No Apparent Short-Term Cancer Risk From Recalled Valsartan

Users of valsartan contaminated with N-nitrosodimethylamine seem not to have increased cancer risk.

FDA Finds Another Carcinogen in Certain Valsartan Products

FDA Finds Another Carcinogen in Certain Valsartan Products

The FDA warns that it has found a second impurity in three lots of Torrent Pharmaceuticals' valsartan drug products.

Second Impurity Identified in Recalled Valsartan Products

Second Impurity Identified in Recalled Valsartan Products

By

In July, several valsartan medications were recalled due to the detection of N-nitrosodimethylamine, an impurity classified as a probable human carcinogen.

Should Intensive BP Treatment Be Generalized to Adults With Diabetes?

Should Intensive BP Treatment Be Generalized to Adults With Diabetes?

By

Intensive blood pressure therapy is associated with a significantly lower risk for serious cardiovascular events in the adults with diabetes.

Fixed-Dose Combination Pills May Improve Hypertension Outcomes

Fixed-Dose Combination Pills May Improve Hypertension Outcomes

Single-pill, fixed-dose combination treatment may be more effective for improving blood pressure control in older patients.

AHA Updates Scientific Statement on Resistant Hypertension

AHA Updates Scientific Statement on Resistant Hypertension

A correct diagnosis of resistant hypertension is necessary to avoid overmedicating.

Statins, CCBs Confer Long-Term Mortality Benefit in Hypertension

Statins, CCBs Confer Long-Term Mortality Benefit in Hypertension

By

Mortality benefits from atorvastatin- and amlodipine-based antihypertensive treatments extend beyond 10 years of treatment.

Hypertension and Heart Disease May Contribute to Brain Atrophy in MS

Hypertension and Heart Disease May Contribute to Brain Atrophy in MS

By

The presence of heart disease and hypertension may contribute to advanced brain atrophy in patients with multiple sclerosis.

Losartan Potassium Tablets Found in Montelukast Sodium Labeled Lots

Losartan Potassium Tablets Found in Montelukast Sodium Labeled Lots

By

The risk of a mixing-up the treatments is especially high for pregnant women, says the Food and Drug Administration (FDA), as losartan is indicated to treat high blood pressure and could harm or kill a fetus.

New Guidelines Target Pharmacological Hypertension Management to High-Risk Patients

New Guidelines Target Pharmacological Hypertension Management to High-Risk Patients

By

A guideline-based approach directing pharmacological treatment to adults more likely to have CVD events may maximize absolute risk reduction of treatment.

Blood Pressure Goals for an Older Man With Hypertension: Grand Rounds Discussion

Blood Pressure Goals for an Older Man With Hypertension: Grand Rounds Discussion

By

Clinicians weigh in on appropriate blood pressure goals for a 79-year-old man with a mean blood pressure of 147/67 mm Hg.

Positive Link for BMI and Blood Pressure in Chinese Population

Positive Link for BMI and Blood Pressure in Chinese Population

The increase in blood pressure ranged from 0.8 to 1.7 mm Hg per unit BMI in patients who were not taking antihypertensive medication.

Labeling Mix-Up Prompts Recall of HCTZ Bottles That May Contain Another Diuretic

Labeling Mix-Up Prompts Recall of HCTZ Bottles That May Contain Another Diuretic

By

To date, there have been no reports of any adverse events related to this recall.

More Targeted Sodium Reduction Strategies Proposed

More Targeted Sodium Reduction Strategies Proposed

By

New study suggests sodium intake is associated with cardiovascular disease and stroke only when mean sodium intake exceeds 5 grams per day.

Increased First-Trimester HbA1c Predicts Gestational Diabetes

Increased First-Trimester HbA1c Predicts Gestational Diabetes

First-trimester HbA1c significantly improved gestational diabetes prediction compared with conventional risk factors.

Extreme Preterm Infants at Risk for Early Age High Blood Pressure

Extreme Preterm Infants at Risk for Early Age High Blood Pressure

By

Children who were born as extreme preterm infants may have a higher risk for high blood pressure and hypertension.

Case: Hypertensive Crisis Following Use of Armodafinil + MAOI

Case: Hypertensive Crisis Following Use of Armodafinil + MAOI

By

This case involved a 36-year-old female with bipolar disorder who presented to the emergency department (ED) with blurry vision, neck stiffness and the "worst headache of (her) life" after taking armodafinil with tranylcypromine.

Triple Combination Pill Can Improve Blood Pressure Control

Triple Combination Pill Can Improve Blood Pressure Control

The proportion of patients achieving target blood increased with the use of a triple combination pill vs usual care at 6 months.

Sign Up for Free e-Newsletters